Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.37m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Form 8 (OPD) - Science Group plc

26 Sep 2018 07:00

RNS Number : 9055B
Science Group PLC
26 September 2018
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Science Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Science Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

25 September 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 1 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

N/A

N/A

N/A

N/A

(2) Cash-settled derivatives:

 

N/A

N/A

N/A

N/A

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

N/A

N/A

N/A

 

TOTAL:

N/A

N/A

N/A

N/A

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Ordinary Shares of 1 pence each held by directors of Science Group plc

 

 

Director

Science Group Ordinary Shares

% of Science Group issued share capital

Martin Ratcliffe

13,412,906

33.51%

David Courtley

375,000

0.94%

Rebecca Archer

60,000

0.15%

 

(b) Science Group plc 2013 Performance Share Plan granted to directors of Science Group plc

 

Director

Maximum number of ordinary shares awarded

Date of grant

Exercise price

Exercise period

Rebecca Archer

25,000

3 Sep 2015

1.0 pence

3 Sep 2018 to 3 Sep 2025

Rebecca Archer

25,000

12 Aug 2016

1.0 pence

12 Aug 2019 to 12 Aug 2026

Rebecca Archer

25,000

6 Sep 2017

1.0 pence

6 Sep 2020 to 6 Sep 2027

Rebecca Archer

100,000

14 May 2018

1.0 pence

14 May 2023 to 14 May 2028

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

26 September 2018

Contact name:

Sarah Cole,

Group Legal Counsel & Company Secretary

Telephone number:

01223 875200

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEEALNSALFPEFF
Date   Source Headline
6th Jun 20193:30 pmRNSInvestment in Frontier Smart Technologies Grp Ltd
29th May 20197:00 amRNSHolding(s) in Company
29th May 20197:00 amRNSTreasury shares issued
23rd May 20197:00 amRNSTreasury shares issued
21st May 20197:00 amRNSHolding(s) in Company
20th May 20197:00 amRNSTermination of Discussions and Holding in Company
20th May 20197:00 amRNSInvestment in Frontier Smart Technologies GroupLtd
25th Apr 20197:00 amRNSBoard Appointment
24th Apr 201912:00 pmRNSResult of Annual General Meeting
28th Mar 20197:00 amRNSPosting of documents to shareholders & AGM notice
26th Mar 20197:00 amRNSTransaction in Own Shares
22nd Mar 20197:00 amRNSTransaction in Own Shares
21st Mar 20197:00 amRNSTransaction in Own Shares
18th Mar 20197:00 amRNSTransaction in Own Shares
8th Mar 20197:00 amRNSTransaction in Own Shares
5th Mar 20197:00 amRNSAudited results for year ended 31 December 2018
26th Feb 20197:00 amRNSNotice of Preliminary Results
21st Feb 20193:15 pmRNSTR1: Notification of Major Interest in Shares
20th Feb 20197:00 amRNSExtended Bank Facilities
24th Jan 20197:00 amRNSCorporate Strategic Review
19th Dec 20187:00 amRNSTransaction in Own Shares
18th Dec 20187:00 amRNSTR1: Notification of Major Interest in Shares
17th Dec 20182:33 pmRNSForm 8.3 - Science Group plc
14th Dec 201812:13 pmRNSForm 8.3 - Science Group plc
14th Dec 20187:00 amRNSTrading Update; Termination of Formal Sale Process
12th Dec 201812:33 pmRNSForm 8.3 - Science Group plc
7th Dec 201812:10 pmRNSForm 8.3 - Science Group plc
3rd Dec 201812:40 pmRNSForm 8.3 - Science Group plc
3rd Dec 20187:00 amRNSTreasury shares issued & Rule 2.9 announcement
30th Nov 201811:02 amRNSForm 8.3 - Science Group plc
29th Nov 201812:04 pmRNSForm 8.3 - Science Group plc
27th Nov 201810:01 amRNSForm 8.3 - Science Group plc
27th Nov 201810:00 amRNSFinance Director maternity leave
26th Nov 20182:23 pmRNSForm 8.3 - Science Group plc
21st Nov 201810:55 amGNWForm 8.3 - [Science Group plc]
21st Nov 20187:58 amRNSForm 8.5 (EPT/RI) - Science Group PLC
15th Nov 20188:56 amRNSForm 8.5 (EPT/RI) - Science Group Plc
14th Nov 20188:15 amRNSForm 8.5 (EPT/RI) - Science Group PLC
13th Nov 20187:00 amRNSTreasury shares issued & Rule 2.9 Announcement
5th Nov 20189:22 amRNSForm 8.5 (EPT/RI) - Science Group PLC
31st Oct 201810:07 amGNWForm 8.3 - Science Group Plc
30th Oct 20188:16 amRNSForm 8.5 (EPT/RI) - Science Group PLC
29th Oct 20185:24 pmRNSForm 8.3 - Science Group PLC
29th Oct 20187:00 amRNSTreasury shares issued & Rule 2.9 Announcement
24th Oct 20181:29 pmRNSForm 8.3 - Science Group plc
17th Oct 20187:00 amRNSRule 2.9 Announcement
16th Oct 20187:00 amRNSTreasury shares issued
9th Oct 20182:41 pmRNSForm 8.3 - Science Group Plc
9th Oct 20188:51 amRNSForm 8.5 (EPT/RI) - Science Group PLC
8th Oct 20182:01 pmRNSForm 8.3 - Science Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.